Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06311435 · ClinicalTrials.gov registry record · NA
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
A NA study of Long COVID, sponsored by MaxWell Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 224
- Enrollment target
- 3
- Study locations
NCT06311435: Recruiting NA study of Long COVID, sponsored by MaxWell Clinic.
NCT06311435 is a NA study of Long COVID that is actively recruiting participants, run by MaxWell Clinic. The registered enrollment target is 224 participants, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06311435, a NA study of Long COVID, is actively recruiting participants, sponsored by MaxWell Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
- 3
- Study locations
Study Summary
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.
Primary Outcome
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID
Conditions Studied
Interventions
- DIAGNOSTIC_TEST RNA Biomarker Blood Test
Study Locations (3)
Tennessee
- The MaxWell Clinic - Brentwood
- The MaxWell Clinic - Brentwood
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
What NCT06311435 shows while recruiting
NCT06311435 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which RNA Biomarker Blood Test is the first listed.
NCT06311435 reports a single indexed study location in Tennessee, Iowa.
Frequently Asked Questions
What is clinical trial NCT06311435 about?
NCT06311435 is a clinical study titled "Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19". The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share ...
What is the current status of trial NCT06311435?
This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2024-03-15. Estimated completion is 2026-03-15.
What conditions does trial NCT06311435 study?
This clinical trial studies the following conditions: Long COVID.
What interventions are being tested in trial NCT06311435?
The interventions under investigation include: RNA Biomarker Blood Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06311435?
This trial is sponsored by MaxWell Clinic, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06311435 being conducted?
This trial has 3 study locations across Iowa, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06311435's enrollment target sits among peer trials
224 14th of 50 higher than 37 of 50 other Long COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Sauna for Long Covid
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI